Lyra Therapeutics (LYRA) Other financing activities (2020 - 2025)
Quarterly Other financing activities rose 1500.0% to $368000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $391000.0 through Dec 2025, up 34.83% year-over-year, with the annual reading at $726000.0 for FY2025, 150.34% up from the prior year.
Lyra Therapeutics' Other financing activities history spans 6 years, with the latest figure at $368000.0 for Q3 2025.
- Other financing activities came in at $368000.0 for Q3 2025, up from $23000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.0 million in Q2 2022 to a low of $2000.0 in Q1 2022.
- The 5-year median for Other financing activities is $169000.0 (2024), against an average of $522272.7.
- Year-over-year, Other financing activities tumbled 99.92% in 2021 and then soared 1500.0% in 2025.
- Lyra Therapeutics' Other financing activities stood at $4000.0 in 2021, then soared by 5800.0% to $236000.0 in 2022, then skyrocketed by 36.44% to $322000.0 in 2023, then crashed by 92.86% to $23000.0 in 2024, then skyrocketed by 1500.0% to $368000.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Other financing activities are $368000.0 (Q3 2025), $23000.0 (Q3 2024), and $98000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 368,000.00 |
| Sep 30, 2025 | 368,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Dec 31, 2023 | 322,000.00 |
| Dec 31, 2023 | 322,000.00 |
| Sep 30, 2023 | 420,000.00 |
| Sep 30, 2023 | 420,000.00 |
| Sep 30, 2022 | 236,000.00 |
| Sep 30, 2022 | 236,000.00 |
| Jun 30, 2022 | 4.01 Mn |
| Jun 30, 2022 | 4.01 Mn |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 95,000.00 |
| Sep 30, 2021 | 95,000.00 |
| Dec 31, 2020 | 4.73 Mn |
| Dec 31, 2020 | 4.73 Mn |
| Sep 30, 2020 | -5.46 Mn |
| Sep 30, 2020 | -5.46 Mn |
| Jun 30, 2020 | 7.07 Mn |
| Jun 30, 2020 | 7.07 Mn |
| Mar 31, 2020 | 773,000.00 |
| Mar 31, 2020 | 773,000.00 |